Sanofi to establish API player
Big Pharma giant Sanofi has announced plans to create a stand-alone company dedicated to the production and marketing of APIs to third parties.
ECHA checking more dossiers
The European Chemicals Agency (ECHA) has revealed that it conducted 301 in-depth checks on almost 3,000 REACH registration dossiers in 2019, covering 274 unique chemicals.
Non-compliance on the rise, says CEFIC
CEFIC has reported that there were 1,468 instances of chemicals in consumer products that were not in compliance with regulations in 2019, 24% up on 2018.
Wacker starts ‘shaping the future’
Wacker Chemie has announced its initial plans for its ‘Shape the Future’ efficiency programme in anticipation of what CEO Rudolf Staudigl called “a harsher competitive environment”.
MCG invests in SPHP
Japan’s Mitsubishi Gas Chemical (MCG) has revealed that it is building an industrial hydrogen peroxide at the site of its Taiwanese subsidiary. Due onstream in early 2020, this will have capacity of some 40,000 tonnes/year.
MCG further said that this is part of its plans to grow in with super-pure hydrogen peroxide (SPHP) for electronic applications. SPHP is widely used in as a cleaning, etching and abrading agent in semiconductor wafer and device.
DuPont board wields the knife
The DuPont board of directors has reappointed Edward Breen as CEO in addition to his role as executive chairman, following disappointing results in 2019. Breen (above) had been chairman and CEO from 2015 to the merger with Dow, was CEO of DowDuPont until their merger was completed and had taken a board role at Corteva, the split-out crop protection company, since 2019.
Givaudan completes Ungerer buy
Givaudan, the world’s largest flavours and fragrances (F&F) house, today completed the acquisition of Ungerer & Company, which was originally announced in November 2019. Terms were not disclosed, but Givaudan said that the newly acquired business would have represented about $250 million of incremental sales in 2019 on a pro forma basis.
